+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

P09.04Adoptive T cell therapy for Idh1R132H-mutated low-grade glioma



P09.04Adoptive T cell therapy for Idh1R132H-mutated low-grade glioma



Neuro-Oncology 18(Suppl_4): iv60




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067458586

Download citation: RISBibTeXText

DOI: 10.1093/neuonc/now188.213


Related references

OS2.6Identification of IDH1R132H-specific T cell receptors from a humanized mouse model and from glioma patients treated with an IDH1R132H-specific peptide vaccine. Neuro-Oncology 18(Suppl_4): Iv5-Iv6, 2016

Os09.9 Identification of Idh1R132H-specific T cell receptors from glioma patients and from Mhc-humanized mice. Neuro-Oncology 19(Suppl_3): iii20, 2017

EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines. Clinical Cancer Research 15(18): 5753-5761, 2009

A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma. Journal of Clinical Medicine 8(2):, 2019

Assessment of efficacy of dendritic cell therapy and viral therapy in high grade glioma clinical trials. A meta-analytic review. Journal of Immunoassay and Immunochemistry 40(1): 70-80, 2019

O4.08 * Agi5198, An Inhibitor Of Idh1R132H, Protects Idh1R132H Hct116 Cells Against Irradiation. Neuro-Oncology 16(Suppl 2): ii8-ii9, 2014

Lgg-07. Low-Grade Glioma Combination Chemotherapy May Be Effective In Braf V600E Codon-Mutated Optic Pathway Gangliogliomas. Neuro-Oncology 19(Suppl_4): iv34, 2017

Spontaneous in vitro senescence of glioma cells confirmed by an antibody against IDH1R132H. Anticancer Research 34(6): 2859-2867, 2014

Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma. Proceedings of the National Academy of Sciences of the United States of America 111(39): 14217-14222, 2014

IDH1R¹³²H decreases the proliferation of U87 glioma cells through upregulation of microRNA-128a. Molecular Medicine Reports 12(5): 6695-6701, 2015

First experiences in treatment of low-grade glioma grade I and II with proton therapy. Radiation Oncology 7: 189, 2012

A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation. Biochemical and Biophysical Research Communications 390(3): 547-551, 2009

Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with Bevacizumab-based therapy at diagnosis. Journal of Neuro-Oncology 121(3): 591-598, 2015

Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients. Oncology Reports 31(4): 1683-1690, 2014

Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients. Clinical Cancer Research 23(12): 2951-2960, 2017